Discover Algeria | About us | Press area | Contact |
This measure allowed the marketing of 320 local medicines, pending registration for several years, thanks to the instructions given by the Ministry of Pharmaceutical Industry to the ANPP to complete the registration of medicines via the automatic validation of the medicines. prices offered by pharmaceutical companies, the same source said.
In 2020, the measures for signing receipts for payment of registration fees were simplified, which made it possible to reduce the time limit for issuing these documents to 48 hours instead of 12 to 18 months previously.
In the context of digitization, a collaboration has been established with the National Institute of Informatics (INI) for the digitization of the measures for issuing import programs and recording and validation measures in addition to the monitoring and control of stocks of drugs.
In addition, the ministry recalled that its action plan was based on 8 axes which are the revision of the current legislation, the establishment of an appropriate general organizational framework and the formulation of an organization capable of allowing 'ANPP to regulate the activities of pharmaceutical companies, to develop the pharmaceutical industry, to regulate the market, to relaunch strategic watch, in addition to administrative simplification and digitization.
On the organizational level, six (06) ministerial directorates were created, including four (04) technical directorates: the directorate of production, industrial development and the promotion of exports and research, the directorate of pharmaceutical activities and regulation, the information systems and documentation department as well as the strategic watch department.
A new regulatory framework has also been developed for the effective establishment of registration and certification committees, as well as of the intersectoral economic committee for drugs in order to enable it to carry out its tasks and make up for the delay observed.
In addition, the ministry's report shows the preparation of a draft executive decree relating to pharmaceutical establishments.
The text will make it possible to verify the territoriality of pharmaceutical responsibility, with a view to guaranteeing the availability and quality of pharmaceutical products and defining the five types of pharmaceutical establishments and the related specifications (manufacture - import - export - distribution - exploitation ).
With regard to the regulation of the national market, a "strict" control system has been set up for the import operations of pharmaceutical products and medical devices, by presenting, obligatorily, "a regulation certificate" during the bank pre-domiciliation intended for the importation of products issued by the services of the ministry, in the sense that 5,849 certificates were submitted until the end of 2020.
As part of the strategic watch on availability, a committee organized in the form of an observatory has been set up, which brings together all the players in the production and marketing of medicines, in order to ensure stability and monitoring. market and anticipate disruptions that may arise.
It was also a question of developing a new policy to set the prices of drugs subject to registration on the basis of an economic and pharmaceutical study, in order to assess the rate of integration, taking into account this takes into account the cost of imported inputs, "which will allow the prioritization of registration for local production".